NMUS - Emerald Bioscience Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development329.96657.865636.621333.364
Selling General and Administrative4,362.5573,801.3643,833.9593,983.746
Non Recurring----
Others----
Total Operating Expenses4,692.5233,859.2294,470.584,317.11
Operating Income or Loss-4,692.523-3,859.229-4,470.58-4,317.11
Income from Continuing Operations
Total Other Income/Expenses Net-14,500.071766.5311,294.087-522.335
Earnings Before Interest and Taxes-4,692.523-3,859.229-4,470.58-4,317.11
Interest Expense-231.955-0.667-0.667-0.667
Income Before Tax-19,192.594-3,092.698-3,176.493-4,839.445
Income Tax Expense1.6421.61.61.716
Minority Interest----
Net Income From Continuing Ops-19,194.236-3,094.298-3,178.093-4,841.161
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-19,194.236-3,094.298-3,178.093-4,841.161
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-19,194.236-4,138.298-3,503.093-4,841.161